Promoting Rational Use of Medicines: Core Components - WHO Policy Perspectives on Medicines, No. 005, September 2002
(2002; 6 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoDefinition of rational use of medicines
Ver el documentoThe problem of irrational use
Ver el documentoAssessing the problem of irrational use
Ver el documentoWorking towards rational use of medicines
Cerrar esta carpetaCore policies to promote more rational use of medicines
Ver el documento1. A mandated multi-disciplinary national body to coordinate medicine use policies
Ver el documento2. Clinical guidelines
Ver el documento3. Essential medicines list based on treatments of choice
Ver el documento4. Drugs and therapeutics committees in districts and hospitals
Ver el documento5. Problem-based training in pharmacotherapy in undergraduate curricula
Ver el documento6. Continuing in-service medical education as a licensure requirement
Ver el documento7. Supervision, audit and feedback
Ver el documento8. Independent medicine information
Ver el documento9. Public education about medicines
Ver el documento10. Avoidance of perverse financial incentives
Ver el documento11. Appropriate and enforced regulation
Ver el documento12. Sufficient government expenditure to ensure availability of medicines and staff
Ver el documentoKey documents
Ver el documentoContacts at WHO Headquarters
 

4. Drugs and therapeutics committees in districts and hospitals

A drugs and therapeutics committee (DTC), also called a pharmacy and therapeutics committee, is a committee designated to ensure the safe and effective use of medicines in the facility or area under its jurisdiction, Such committees are well-established in industrial countries as a successful way of promoting more rational, cost-effective use of medicines in hospitals (Box 5). Governments may encourage hospitals to have DTCs by making it an accreditation requirement to various professional societies. DTC members should represent all the major specialities and the administration; they should also be independent and declare any conflict of interest. A senior doctor would usually be the chairperson and the chief pharmacist, the secretary.

Factors critical to success include: clear objectives; a firm mandate; support by the senior hospital management; transparency; wide representation; technical competence; a multidisciplinary approach; and sufficient resources to implement the DTC's decisions.

Box 5 Responsibilities of a drugs and therapeutics committee

• developing, adapting, or adopting clinical guidelines for the health institution or district;

• selecting cost-effective and safe medicines (hospital/ district drug formulary);

• implementing and evaluating strategies to improve medicine use (including drug use evaluation, and liaison with antibiotic and infection control committees);

• providing on-going staff education (training and printed materials);

• controlling access to staff by the pharmaceutical industry with its promotional activities;

• monitoring and taking action to prevent adverse drug reactions and medication errors;

• providing advice about other drug management issues, such as quality and expenditure.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013